PPMS patients taking Ocrevus are less likely to progress...

Discuss Ocrelizumab, a monoclonal antibody treatment for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

PPMS patients taking Ocrevus are less likely to progress...

Post by MSUK »

PPMS patients taking Ocrevus are less likely to see progression

Having recently concluded an ORATORIO phase III clinical trial of primary progressive multiple sclerosis (PPMS) patients, Genentech’s Ocrevus (ocrelizumab) increased the number of patients found to have no experienced progression (NEP) when taking the drug...Read more - http://www.ms-uk.org/ppms-patients-taki ... ion-100317
MS-UK - http://www.ms-uk.org/
Top
Post Reply

Return to “Ocrevus (Ocrelizumab)”